A. Cometta Et Al. , "Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy," CLINICAL INFECTIOUS DISEASES , vol.37, no.3, pp.382-389, 2003
Cometta, A. Et Al. 2003. Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. CLINICAL INFECTIOUS DISEASES , vol.37, no.3 , 382-389.
Cometta, A., Kern, W., De Bock, R., Paesmans, M., Vandenbergh, M., Crokaert, F., ... Engelhard, D.(2003). Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. CLINICAL INFECTIOUS DISEASES , vol.37, no.3, 382-389.
Cometta, A Et Al. "Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy," CLINICAL INFECTIOUS DISEASES , vol.37, no.3, 382-389, 2003
Cometta, A Et Al. "Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy." CLINICAL INFECTIOUS DISEASES , vol.37, no.3, pp.382-389, 2003
Cometta, A. Et Al. (2003) . "Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy." CLINICAL INFECTIOUS DISEASES , vol.37, no.3, pp.382-389.
@article{article, author={A Cometta Et Al. }, title={Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy}, journal={CLINICAL INFECTIOUS DISEASES}, year=2003, pages={382-389} }